Abstract:Heat shock proteins (Hsps) are a family of abundantly expressed ATP-dependent chaperone proteins. Hsp90 is an eminent member of Hsp family. Thus far, two primary functions have been described for Hsp90: first, as a regulator of conformational change of some protein kinases and nuclear hormone receptors, and the other as an indispensable factor in cellular stress response. Hsp90 has an essential number of interaction proteins since it participates in almost every biological process and its importance is self-evident. Hsp90 has an inextricable relationship in the pathogenesis of cancer, especially in the proliferation and irradiation of cancer cells, thus being a notable cancer target. Since the discovery of geldanamycin, the first inhibitor of Hsp90, from the bacterial species Streptomyces hygroscopicus , even more attention has been focused toward Hsp90. Many structure-based inhibitors of Hsp90 have been designed to develop an innovative method to defeat cancer. However, already designed inhibitors have various deficiencies, such as hepatotoxicity, poor aqueous solubility, instability, and non-ideal oral bioavailability. Based on the aforementioned reasons and to achieve an optimal performance and fewer side effects, we designed a novel inhibitor of Hsp90, called FS5, and resolved the crystal structure of the Hsp90 N -FS5 complex (1.65 Å, PDB code 5XRB). Furthermore, we compared the complexes Hsp90 N , Hsp90 N -GDM, and Hsp90 N -ATP and suggest that the inhibitor FS5 may compete with ATP for binding to Hsp90, which can be regarded as a potential strategy for the development of novel cancer drugs in the future.

Synthesis and Evaluation of 4-(2-hydroxypropyl)piperazin-1-yl) Derivatives As Hsp90 Inhibitors.

Design, Synthesis and Pharmacological Evaluation of 4,5-Diarylisoxazols Bearing Amino Acid Residues Within the 3-Amido Motif As Potent Heat Shock Protein 90 (hsp90) Inhibitors

Discovery of Potent N-(isoxazol-5-yl)amides As HSP90 Inhibitors.

Design, synthesis and biological studies of new isoxazole compounds as potent Hsp90 inhibitors

Identification of a New Series of Potent Diphenol HSP90 Inhibitors by Fragment Merging and Structure-Based Optimization

Discovery and development of heat shock protein 90 inhibitors.

Insight into the structural and dynamic properties of novel HSP90 inhibitors through DFT calculations and molecular dynamics simulations

Design, synthesis, and molecular docking studies of novel pyrazolyl 2-aminopyrimidine derivatives as HSP90 inhibitors

Synthesis and evaluation of the antitumor activity of 2-amino-4-tetrahydroindazole-substituted benzamide derivatives as HSP90 inhibitors

Optimization of potent, selective, and orally bioavailable pyrrolodinopyrimidine-containing inhibitors of heat shock protein 90. Identification of development candidate 2-amino-4-{4-chloro-2-[2-(4-fluoro-1H-pyrazol-1-yl)ethoxy]-6-methylphenyl}-N-(2,2-difluoropropyl)-5,7-dihydro-6H-pyrrolo[3,4-d]pyri

Design, synthesis and biological evaluation of a new class of Hsp90 inhibitors vibsanin C derivatives

Probing some recent natural compounds from Phellinus baumii, Colletotrichum sp. and Ligustrum lucidum as heat shock protein 90 inhibitors

Structural aspects of triazole derivatives as HSP90 inhibitors for the treatment of cancer: in silico studies

Structural Determination of Three Different Series of Compounds as Hsp90 Inhibitors Using 3D-QSAR Modeling, Molecular Docking and Molecular Dynamics Methods

[Progress in the study of heat shock protein 90 inhibitors]

Complex structure of human Hsp90 N and a novel small inhibitor FS5

Structure-activity relationship in a purine-scaffold compound series with selectivity for the endoplasmic reticulum Hsp90 paralog Grp94.

Multi-substituted 8-Aminoimidazo[1,2-a]pyrazines by Groebke–Blackburn–Bienaymé Reaction and Their Hsp90 Inhibitory Activity

Design, synthesis, biological evaluation, and docking studies of (s)-phenylalanine derivatives with a 2-cyanopyrrolidine moiety as potent dipeptidyl peptidase 4 inhibitors.

Small Molecule Inhibitors Targeting Heat Shock Protein 90: an Updated Review

Fungal mycotoxin penisuloxazin A, a novel C-terminal Hsp90 inhibitor and characteristics of its analogues on Hsp90 function related to binding sites